Financiere des Professionnels’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Sell
37,670
-1,075
-3% -$58.4K 0.09% 166
2026
Q1
$2.43M Sell
38,745
-4,669
-11% -$374K 0.14% 136
2025
Q4
$4.14M Sell
43,414
-1,253
-3% -$123K 0.23% 96
2025
Q3
$4.36M Sell
44,667
-897
-2% -$92.9K 0.25% 98
2025
Q2
$4.89M Sell
45,564
-18,247
-29% -$1.85M 0.3% 92
2025
Q1
$6.44M Sell
63,811
-17,574
-22% -$1.77M 0.42% 71
2024
Q4
$7.27M Sell
81,385
-1,447
-2% -$127K 0.51% 65
2024
Q3
$6.94M Sell
82,832
-913
-1% -$72K 0.47% 71
2024
Q2
$6.41M Sell
83,745
-51,868
-38% -$3.8M 0.5% 63
2024
Q1
$9.29M Sell
135,613
-39,361
-22% -$2.53M 0.75% 40
2023
Q4
$10.1M Sell
174,974
-6,979
-4% -$373K 0.89% 27
2023
Q3
$9.61M Buy
+181,953
New +$9.54M 0.92% 23

Other funds holding BSX

Financiere des Professionnels's BSX Position: Q2 2026 in Review

Financiere des Professionnels reduced its Boston Scientific (BSX) stake by 2.8% in Q2 2026, selling an estimated $58.4K and leaving 37,670 shares worth $1.61M. The position accounts for 0.09% of the portfolio, ranked #166.

Financiere des Professionnels first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $10.1M in Q4 2023. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Financiere des Professionnels held 37,670 shares of Boston Scientific worth $1.61M as of Q2 2026.
  • Financiere des Professionnels sold 1,075 Boston Scientific shares in Q2 2026, an estimated $58.4K.
  • Boston Scientific made up 0.09% of Financiere des Professionnels's portfolio in Q2 2026, its #166 holding.
  • Financiere des Professionnels first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Financiere des Professionnels's Boston Scientific position peaked at $10.1M in Q4 2023.
  • 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.